Purpose Of This Guidance
C. Purpose of this guidance:
- To outline the practical arrangements for notification.
- To provide advice on what should and what should not be classified as a “serious breach” and what must be reported.
- To outline possible actions that may be taken by the MHRA in response to notifications of serious breaches.
Clinical Research News
Upcoming Clinical Trials
-
NCT03824847Not yet recruitingConditions: Influenza, Human
-
NCT03823833Not yet recruitingConditions: Endometriosis, Dermoid Cyst, Mucinous Cyst
-
NCT03823820Not yet recruitingConditions: Hydration
-
NCT03822585Not yet recruitingConditions: Beta-Thalassemia
-
NCT03822338Not yet recruitingConditions: Ischemia Reperfusion Injury
-
NCT03821389Not yet recruitingConditions: Respiratory Insufficiency
-
NCT03821220Not yet recruitingConditions: Diabetes Mellitus
-
NCT03821181Not yet recruitingConditions: Moyamoya Disease, TIA, Children, Stroke
-
NCT03820999Not yet recruitingConditions: Lyme Neuroborreliosis
-
NCT03820921Not yet recruitingConditions: Pancreatic Cancer
Recent CRA jobs
-
Data Management Lead I (FSP), multiple EMEA locations
-
FSP Clinical Research Associate / FSP 臨床開発モニター(東京・大阪・神戸)
-
Biotech Partnership Enablement, Associate Director
-
Vendor Quality Specialist
-
Advisor - Communications & Engagement
-
Animal Program Support Specialist 1
-
Technician Toxicology
-
Cagewash Technician ($500 sign on bonus)
-
Sr. Manager Biomarkers
-
Senior Manager - Bioanalytical Chemistry